Evidence map›Paper›PMID 33216826›Full record

ArticleOncotarget2020

Detection of

Michael E Clark, Helen Rizos, Michelle R Pereira, Ashleigh C McEvoy, Gabriela Marsavela, Leslie Calapre, Katie Meehan, Olivia Ruhen, Muhammad A Khattak, Tarek M Meniawy and 6 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Michael E ClarkSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Helen RizosFaculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
Michelle R PereiraSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Ashleigh C McEvoySchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Gabriela MarsavelaSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Leslie CalapreSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Katie MeehanDepartment of Otorhinolaryngology, Head and Neck Surgery, Chinese University of Hong Kong, Hong Kong.
Olivia RuhenSchool of Biomedical Science, University of Western Australia, Crawley, Western Australia, Australia.
Muhammad A KhattakSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Tarek M MeniawySchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Georgina V LongMelanoma Institute Australia, Sydney, New South Wales, Australia.
Matteo S CarlinoWestmead Institute for Cancer Research, The University of Sydney, Sydney, New South Wales, Australia.
Alexander M MenziesMelanoma Institute Australia, Sydney, New South Wales, Australia.
Michael MillwardSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Melanie ZimanSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Elin S GraySchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Edith Cowan University · AUUniversity of Western Australia · AUSir Charles Gairdner Hospital · AUUniversity of Sydney · AUChinese University of Hong Kong · CNMacquarie University · AUMelanoma Institute Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The analysis of plasma circulating tumour nucleic acids provides a non-invasive approach to assess disease burden and the genetic evolution of tumours in response to therapy.

Indexed as

BRAF splicingdrug resistanceextracellular vesiclesmelanomatargeted therapy

Identifiers

PMID33216826
PMCPMC7646833
OpenAlexW3094977305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.